Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency seeking participants for website user-testing research 29 Januar 2013NewsCorporateMedicines European Medicines Agency to review third- and fourth-generation combined oral contraceptives 28 Januar 2013Press releaseCorporateMedicines Novartis Europharm Ltd withdraws its marketing-authorisation application for Ruvise (imatinib mesilate) 24 Januar 2013Press releaseHuman Updated formatted table template for dossier submission available 24 Januar 2013NewsCorporate European Medicines Agency publishes guidance on preparing and reviewing summaries of product characteristics 21 Januar 2013NewsCorporateMedicines Framework for a close collaboration with Israel in place 21 Januar 2013NewsCorporate European Medicines Agency recommends approval of medicine for treatment of vitreomacular traction 18 Januar 2013Press releaseCorporateMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 January 2013 18 Januar 2013NewsHuman European Medicines Agency confirms recommendation to suspend Tredaptive, Pelzont and Trevaclyn 18 Januar 2013Press releaseHumanMedicines eSubmission Gateway release II and eSubmission web client now live for all applications for human medicines 15 Januar 2013NewsCorporate 1 … 236 237 238 239 240 Page 240 of 384 241 242 243 244 … 384
European Medicines Agency seeking participants for website user-testing research 29 Januar 2013NewsCorporateMedicines
European Medicines Agency to review third- and fourth-generation combined oral contraceptives 28 Januar 2013Press releaseCorporateMedicines
Novartis Europharm Ltd withdraws its marketing-authorisation application for Ruvise (imatinib mesilate) 24 Januar 2013Press releaseHuman
European Medicines Agency publishes guidance on preparing and reviewing summaries of product characteristics 21 Januar 2013NewsCorporateMedicines
European Medicines Agency recommends approval of medicine for treatment of vitreomacular traction 18 Januar 2013Press releaseCorporateMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 January 2013 18 Januar 2013NewsHuman
European Medicines Agency confirms recommendation to suspend Tredaptive, Pelzont and Trevaclyn 18 Januar 2013Press releaseHumanMedicines
eSubmission Gateway release II and eSubmission web client now live for all applications for human medicines 15 Januar 2013NewsCorporate